IC
AXSM icon

Ikarian Capital’s Axsome Therapeutics AXSM Stock Holding History

Ikarian Capital’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100,000
Closed -$8.46M – 170
2024
Q4 		$8.46M Buy
+100,000
New +$9.2M 1.15% 19
2023
Q2 		– Sell
-150,000
Closed -$9.25M – 135
2023
Q1 		$9.25M Buy
+150,000
New +$9.85M 2.1% 9
2022
Q3 		– Sell
-350,000
Closed -$13.4M – 114
2022
Q2 		$13.4M Buy
+350,000
New +$11.1M 2.44% 9
2020
Q3 		– Sell
-18,300
Closed -$1.51M – 180
2020
Q2 		$1.51M Sell
18,300
-356,700
-95% -$27.5M 0.12% 114
2020
Q1 		$22.1M Buy
+375,000
New +$30.6M 1.66% 9

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return